Treatment of Disseminated Mycobacterial Infection with High-Dose IFN-γ in a Patient with IL-12Rβ1 Deficiency
Figure 2
The percent increase in T cell proliferation stimulated with PHA and IL2 in control and the three samples from the patient: (S1) before treatment, (S2) 6 months after treatment (S3) 12 months after treatment. The percent increase in Sample, (S3) stimulation with PHA was significantly higher than the response before treatment (S1) (), while no significant difference with IL2.
